Replies to post #30568 on Abattis Bioceuticals Corp (ATTBF)

[guay]

GreenBrickRoad, I believe the added value of selling phalf of NVL will be much higher than we can estimate at the moment. The added value is not only that Emerald is now responsible for half of the maintenance costs, but will also contribute through orders to ensure the existence of the laboratory. Furthermore, I believe that Abattis will invest the capital now available in its other business areas - in my opinion also in cooperation with Emerald - see, ia. BioCube.

Biocube - provides controlled cannabis cultivation environments for high yield marijuana growing. The company has exclusive worldwide rights to a building product derived from magnesium oxide known as MgO board, which has applications in all areas of the building and construction industry as a fireproof, antimicrobial, antibacterial, waterproof, and recyclable material.

Biocell Labs Inc. - is a wholly-owned subsidiary focused on providing standardized pharmaceutical-grade products. Currently, the company has 13 proprietary formulations for out-licensing to cosmetic, nutraceutical and pharmaceutical companies.

[guay]

In this article, we will look at some of the benefits of the transaction for both parties and why investors may want to take notice ...
http://420meta.com/emerald-health-expands-capabilities-with-northern-vine-labs/

Abattis Bioceuticals benefits from Emerald Health’s wealth of scientific knowledge, pharmaceutical connections, and access to capital, as well as a $2.5 million capital infusion into the subsidiary. The strong relationship between Abattis and a rapidly growing and respected licensed producer in Canada also paves the way for future joint ventures for its extraction technology and adds credibility to its ability to create laboratories – which is essential to its business model moving forward.
http://420meta.com/emerald-health-expands-capabilities-with-northern-vine-labs/